7
Participants
Start Date
July 12, 2000
Primary Completion Date
October 5, 2001
Study Completion Date
September 24, 2002
monoclonal antibody hu3S193
Memorial Sloan-Kettering Cancer Center, New York
Lead Sponsor
Ludwig Institute for Cancer Research
OTHER